Riskpilot← Back to searchSign inGet full accessÖronkliniken Bromma AB
ABActiveOrg 5592049653Klädesvägen 12 3 TrGeneral medical practice activities · NACE 8621Est. 20195-9 employees
Revenue 2024
SEK 6M
+23% vs 2023
EBITDA margin
36.0%
+23% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
SEK 1,5M
+30% vs 2023
| Revenue | SEK 6M | +23% |
| EBITDA | SEK 2,1M | +23% |
| Net profit | SEK 1,5M | +30% |
| Total assets | SEK 6,4M | +10% |
| Equity | SEK 6M | +9% |
| Employees | — | — |
Legal name
Öronkliniken Bromma AB
Org number
5592049653
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 maj 2019
Share capital
SEK 50 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet skall vara öron, näsa, hals klinik och därmed förenlig verksamhet.
Address
Klädesvägen 12 3 Tr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 481 | 6 044 | 5 132 | 4 868 | 5 971 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 877 | 2 895 | 2 403 | 1 751 | 2 147 |
| Depreciation & amort. | −265 | −301 | −313 | −298 | −270 |
| EBIT | 2 612 | 2 594 | 2 090 | 1 453 | 1 877 |
| Net financials | −59 | — | −6 | −8 | 5 |
| Profit before tax | 2 554 | 2 594 | 2 085 | 1 446 | 1 882 |
| Tax | −445 | −534 | −432 | −299 | −387 |
| Net profit | 2 109 | 2 060 | 1 653 | 1 147 | 1 495 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 193 | 5 101 | 6 328 | 5 805 | 6 390 |
| Equity | 2 139 | 3 739 | 5 391 | 5 538 | 6 033 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 054 | 1 363 | 936 | 267 | 356 |
| Total debt | 2 054 | 1 363 | 936 | 267 | 356 |
EBITDA margin
36.0%
This company
15.8%
Market median
+128% vs market
20202024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20202024
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20202024
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC | Audit | 2022 |
| Former (1) | ||
PJ Auditor Substitute | Auditor Substitute | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (2) | ||
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Öronkliniken Bromma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pierre Jibro | Auditor Substitute | 0 companies |
| Malin Christina Evesäter | Audit | 0 companies |
| Konstantinos Potsis | Board of Directors | 0 companies |
| Zheer Saleh Tawfique | Chairman | 0 companies |
| Tarza Jalal Faraj Soran | Deputy Board Member | 0 companies |
| Eleni Danou | Deputy Board Member | 0 companies |